Cargando…
Modeling Human Cancer-induced Cachexia
Cachexia is a wasting syndrome characterized by pronounced skeletal muscle loss. In cancer, cachexia is associated with increased morbidity and mortality and decreased treatment tolerance. Although advances have been made in understanding the mechanisms of cachexia, translating these advances to the...
Autores principales: | Talbert, Erin E., Cuitiño, Maria C., Ladner, Katherine J., Rajasekerea, Priyani V., Siebert, Melissa, Shakya, Reena, Leone, Gustavo W., Ostrowski, Michael C., Paleo, Brian, Weisleder, Noah, Reiser, Peter J., Webb, Amy, Timmers, Cynthia D., Eiferman, Daniel S., Evans, David C., Dillhoff, Mary E., Schmidt, Carl R., Guttridge, Denis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733019/ https://www.ncbi.nlm.nih.gov/pubmed/31390573 http://dx.doi.org/10.1016/j.celrep.2019.07.016 |
Ejemplares similares
-
Modeling human cancer cachexia in colon 26 tumor-bearing adult mice
por: Talbert, Erin E., et al.
Publicado: (2014) -
Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients
por: Talbert, Erin E., et al.
Publicado: (2018) -
The impact of inflammation and acute phase activation in cancer cachexia
por: Robinson, Tyler P., et al.
Publicado: (2023) -
Inflammation Based Regulation of Cancer Cachexia
por: Onesti, Jill K., et al.
Publicado: (2014) -
Inflammation as a Therapeutic Target in Cancer Cachexia
por: Clamon, Gerald, et al.
Publicado: (2022)